Protocol CA012-0; A CONTROLLED randomized, phase III, multicenter, Open label study of ABI-007 (A Cremophor Free, protien stabilized, Nanoparticle Paclitaxel) and Taxol In patients with Breast Cancer

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleProtocol CA012-0; A CONTROLLED randomized, phase III, multicenter, Open label study of ABI-007 (A Cremophor Free, protien stabilized, Nanoparticle Paclitaxel) and Taxol In patients with Breast Cancer
StatusFinished
Effective start/end date1/01/02 → 31/12/03

Funding

  • AMERICAN BIOSCIENCE INC